|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 18, 2023 08:18AM
|
|
Re: Hepalink IPO Document and what it says about RVX
|
2
|
Resverlogix Corp.
|
Jan 27, 2020 08:03AM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
2
|
Zenith Epigenetics
|
Sep 03, 2018 06:06AM
|
|
Re: An email and response from another poster.
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 05:43PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
2
|
Resverlogix Corp.
|
Apr 29, 2022 02:45PM
|
|
Re: Saudi
|
2
|
Resverlogix Corp.
|
Jan 13, 2021 10:17AM
|
|
Re: I think one major reason that,
|
2
|
Resverlogix Corp.
|
Nov 02, 2019 10:30AM
|
|
Re: My guess is a second BTD is coming
|
2
|
Resverlogix Corp.
|
Feb 08, 2020 07:56PM
|
|
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
2
|
Resverlogix Corp.
|
Apr 27, 2020 01:10PM
|
|
Re: you won’t see anyone buying this
|
2
|
Zenith Epigenetics
|
Dec 06, 2023 01:45PM
|
|
Warrants
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 25, 2019 09:04AM
|
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Aug 18, 2019 04:59PM
|
|
Re: Yes , it seems like a hundred years ago...
|
2
|
Resverlogix Corp.
|
Mar 08, 2021 11:02AM
|
|
Re: Looking forward to the short interest update....
|
2
|
Resverlogix Corp.
|
Oct 19, 2019 06:28AM
|
|
Re: share value/little perspective
|
2
|
Resverlogix Corp.
|
Sep 03, 2021 12:08PM
|
|
Re: Under the radar....
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 16, 2020 01:05PM
|
|
RVX LEVEL II
|
2
|
Resverlogix Corp.
|
Aug 14, 2020 01:30PM
|
|
Re: Option #2 and Option #3 questions
|
2
|
Resverlogix Corp.
|
Oct 27, 2020 03:38PM
|
|
Re: HL USA - Material or not?
|
2
|
Resverlogix Corp.
|
Apr 11, 2019 11:35AM
|
|
Re: Management change at Resverlogix
|
2
|
Resverlogix Corp.
|
Jul 06, 2021 09:13AM
|
